184 related articles for article (PubMed ID: 11294758)
1. Enhanced renal expression of preproendothelin mRNA during chronic angiotensin II hypertension.
Alexander BT; Cockrell KL; Rinewalt AN; Herrington JN; Granger JP
Am J Physiol Regul Integr Comp Physiol; 2001 May; 280(5):R1388-92. PubMed ID: 11294758
[TBL] [Abstract][Full Text] [Related]
2. Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure.
Alexander BT; Rinewalt AN; Cockrell KL; Massey MB; Bennett WA; Granger JP
Hypertension; 2001 Feb; 37(2 Pt 2):485-9. PubMed ID: 11230323
[TBL] [Abstract][Full Text] [Related]
3. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.
Allcock GH; Venema RC; Pollock DM
Am J Physiol; 1998 Jul; 275(1):R245-52. PubMed ID: 9688985
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic, renal, and endocrine responses to acute ET(A) blockade at different ANG II plasma levels.
Boemke W; Hocher B; Schleyer N; Krebs MO; Kaczmarczyk G
Am J Physiol Regul Integr Comp Physiol; 2001 May; 280(5):R1322-31. PubMed ID: 11294750
[TBL] [Abstract][Full Text] [Related]
5. Regulation of angiotensin II type 1 receptor mRNA and protein in angiotensin II-induced hypertension.
Harrison-Bernard LM; El-Dahr SS; O'Leary DF; Navar LG
Hypertension; 1999 Jan; 33(1 Pt 2):340-6. PubMed ID: 9931127
[TBL] [Abstract][Full Text] [Related]
6. Sex-Specific Effect of Endothelin in the Blood Pressure Response to Acute Angiotensin II in Growth-Restricted Rats.
Intapad S; Ojeda NB; Varney E; Royals TP; Alexander BT
Hypertension; 2015 Dec; 66(6):1260-6. PubMed ID: 26459423
[TBL] [Abstract][Full Text] [Related]
7. Prevention of the cardiovascular and renal effects of angiotensin II by endothelin blockade.
Herizi A; Jover B; Bouriquet N; Mimran A
Hypertension; 1998 Jan; 31(1):10-4. PubMed ID: 9449383
[TBL] [Abstract][Full Text] [Related]
8. Contribution of renal purinergic receptors to renal vasoconstriction in angiotensin II-induced hypertensive rats.
Franco M; Bautista R; Tapia E; Soto V; Santamaría J; Osorio H; Pacheco U; Sánchez-Lozada LG; Kobori H; Navar LG
Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1301-9. PubMed ID: 21367914
[TBL] [Abstract][Full Text] [Related]
9. Local renal medullary L-NAME infusion enhances the effect of long-term angiotensin II treatment.
Szentiványi M; Maeda CY; Cowley AW
Hypertension; 1999 Jan; 33(1 Pt 2):440-5. PubMed ID: 9931144
[TBL] [Abstract][Full Text] [Related]
10. Antioxidants block angiotensin II-induced increases in blood pressure and endothelin.
Ortiz MC; Manriquez MC; Romero JC; Juncos LA
Hypertension; 2001 Sep; 38(3 Pt 2):655-9. PubMed ID: 11566950
[TBL] [Abstract][Full Text] [Related]
11. Impairment of pressure-natriuresis and renal autoregulation in ANG II-infused hypertensive rats.
Wang CT; Chin SY; Navar LG
Am J Physiol Renal Physiol; 2000 Aug; 279(2):F319-25. PubMed ID: 10919852
[TBL] [Abstract][Full Text] [Related]
12. Effects of endothelin receptor antagonists on renal hemodynamics in angiotensin II-infused rats on high NaCl intake.
Saeed A; Dibona GF; Guron G
Kidney Blood Press Res; 2012; 36(1):258-67. PubMed ID: 23171921
[TBL] [Abstract][Full Text] [Related]
13. Role of ET(A) receptors in experimental ANG II-induced hypertension in rats.
Ballew JR; Fink GD
Am J Physiol Regul Integr Comp Physiol; 2001 Jul; 281(1):R150-4. PubMed ID: 11404288
[TBL] [Abstract][Full Text] [Related]
14. Role of endothelin in mediating postmenopausal hypertension in a rat model.
Yanes LL; Romero DG; Cucchiarelli VE; Fortepiani LA; Gomez-Sanchez CE; Santacruz F; Reckelhoff JF
Am J Physiol Regul Integr Comp Physiol; 2005 Jan; 288(1):R229-33. PubMed ID: 15319224
[TBL] [Abstract][Full Text] [Related]
15. ETA receptor blockade prevents hypertension associated with exogenous endothelin-1 but not renal mass reduction in the rat.
Pollock DM; Polakowski JS
J Am Soc Nephrol; 1997 Jul; 8(7):1054-60. PubMed ID: 9219154
[TBL] [Abstract][Full Text] [Related]
16. Effects of endothelin-A receptor antagonism on bilateral renal function in renovascular hypertensive rats.
Kassab S; Hamdy H; AbdulGhaffar T; Granger JP
Fundam Clin Pharmacol; 2001 Dec; 15(6):379-85. PubMed ID: 11860525
[TBL] [Abstract][Full Text] [Related]
17. Adverse effects of pneumoperitoneum on renal function: involvement of the endothelin and nitric oxide systems.
Abassi Z; Bishara B; Karram T; Khatib S; Winaver J; Hoffman A
Am J Physiol Regul Integr Comp Physiol; 2008 Mar; 294(3):R842-50. PubMed ID: 18160528
[TBL] [Abstract][Full Text] [Related]
18. Renal nerves promote sodium excretion in angiotensin-induced hypertension.
Lohmeier TE; Hildebrandt DA
Hypertension; 1998 Jan; 31(1 Pt 2):429-34. PubMed ID: 9453340
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II infused intrarenally causes preglomerular vascular changes and hypertension.
Stevenson KM; Edgley AJ; Bergström G; Worthy K; Kett MM; Anderson WP
Hypertension; 2000 Nov; 36(5):839-44. PubMed ID: 11082153
[TBL] [Abstract][Full Text] [Related]
20. Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II.
Alonso-Galicia M; Maier KG; Greene AS; Cowley AW; Roman RJ
Am J Physiol Regul Integr Comp Physiol; 2002 Jul; 283(1):R60-8. PubMed ID: 12069931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
